Evidence map›Paper›PMID 31209889›Full record

ArticleInternational journal of cancer2020

DNA repair and cancer in colon and rectum: Novel players in genetic susceptibility.

Barbara Pardini, Alda Corrado, Elisa Paolicchi, Giovanni Cugliari, Sonja I Berndt, Stephane Bezieau, Stephanie A Bien, Hermann Brenner, Bette J Caan, Peter T Campbell and 31 more

Open access · greenAbstract read
In one paragraph

Article in International journal of cancer, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 49 citations in OpenAlex.

  1. Germline Predisposition to Oncogenic Alkylating Damage in Colorectal Cancer.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Gene-Environment Analyses in a UK Biobank Skin Cancer Cohort Identifies Important SNPs in DNA Repair Genes That May Help Prognosticate Disease Risk.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2023
    Article
  7. Article
  8. Article
  9. The role of DNA mismatch repair in immunotherapy of human cancer.International journal of biological sciences · 2022
    Review
  10. Article
  11. Article
  12. Article
  13. DNA Mismatch Repair Gene Variants in Sporadic Solid Cancers.International journal of molecular sciences · 2020
    Review
  14. Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

41 authors at 20 institutions in 8 countries.

Barbara PardiniItalian Institute for Genomic Medicine (IIGM), Turin, Italy.ORCID 0000-0001-9571-4257
Alda CorradoDepartment of Biology, University of Pisa, Pisa, Italy.
Elisa PaolicchiDepartment of Biology, University of Pisa, Pisa, Italy.
Giovanni CugliariItalian Institute for Genomic Medicine (IIGM), Turin, Italy.
Sonja I BerndtDivision of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD.
Stephane BezieauService de Génétique Médicale, Centre Hospitalier Universitaire (CHU), Nantes, France.
Stephanie A BienPublic Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA.
Hermann BrennerDivision of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Bette J CaanKaiser Permanente Medical Care Program of Northern California, Oakland, CA.
Peter T CampbellEpidemiology Research Program, American Cancer Society, Atlanta, GA.
Graham CaseyPublic Health Sciences, University of Virginia, Charlottesville, VA.
Andrew T ChanDivision of Gastroenterology, Massachusetts General Hospital, Boston, MA.
Jenny Chang-ClaudeDivision of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Michelle CotterchioPrevention and Cancer Control, Cancer Care Ontario, Toronto, ON, Canada.
Manish GalaDivision of Gastroenterology, Massachusetts General Hospital, Boston, MA.
Steven J GallingerDepartment of Surgery, Mount Sinai Hospital, Toronto, ON, Canada.
Robert W HaileStanford University School of Medicine, Stanford, CA.
Tabitha A HarrisonPublic Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA.
Richard B HayesDivision of Epidemiology, Department of Population Health, New York University School of Medicine, New York, NY.
Michael HoffmeisterDivision of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany.ORCID 0000-0002-8307-3197
John L HopperMelbourne School of Population Health, The University of Melbourne, Melbourne, VIC, Australia.
Li HsuPublic Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA.
Jeroen HuyghePublic Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA.
Mark A JenkinsMelbourne School of Population Health, The University of Melbourne, Melbourne, VIC, Australia.
Loic Le MarchandEpidemiology Program, Research Cancer Center of Hawaii, University of Hawaii, Honolulu, HI.
Yi LinPublic Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA.
Noralane M LindorDepartment of Health Sciences Research, Mayo Clinic Arizona, Scottsdale, AZ.
Hongmei NanDepartment of Epidemiology, Richard M. Fairbanks School of Public Health, Indiana University, Indianapolis, IN.
Polly A NewcombPublic Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA.
Shuji OginoProgram in MPE Molecular Pathological Epidemiology, Department of Pathology, Brigham and Women's Hospital, and Harvard Medical School, Boston, MA.
John D PotterPublic Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA.
Robert E SchoenDepartment of Medicine and Epidemiology, University of Pittsburgh Medical Center, Pittsburgh, PA.
Martha L SlatteryDepartment of Internal Medicine, University of Utah Health Sciences Center, Salt Lake City, UT.ORCID 0000-0002-1655-6543
Emily WhitePublic Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA.
Ludmila VodickovaInstitute of Biology and Medical Genetics, First Faculty of Medicine, Charles University, Prague, Czech Republic.
Veronika VymetalkovaInstitute of Biology and Medical Genetics, First Faculty of Medicine, Charles University, Prague, Czech Republic.
Pavel VodickaInstitute of Biology and Medical Genetics, First Faculty of Medicine, Charles University, Prague, Czech Republic.
Federica GemignaniDepartment of Biology, University of Pisa, Pisa, Italy.
Ulrike PetersPublic Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA.
Alessio NaccaratiItalian Institute for Genomic Medicine (IIGM), Turin, Italy.
Stefano LandiDepartment of Biology, University of Pisa, Pisa, Italy.
Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa · ZACzech Academy of Sciences · CZUniversity of Pisa · ITGerman Cancer Research Center · DEItalian institute for Genomic Medicine · ITMassachusetts General Hospital · USThe University of Melbourne · AUAmerican Cancer Society · USBroad Institute · USCancer Care Ontario · CACentre Hospitalier Universitaire de Nantes · FRKaiser Permanente · USMayo Clinic in Arizona · USMount Sinai Hospital · CANational Institutes of Health · USNew York University · USRichard M. Fairbanks Foundation · USStanford University · USUniversity of Hawaiʻi at Mānoa · USUniversity of Pittsburgh Medical Center · US

Funding

Translational Bioimaging Core Shared ResourceP30CA015704 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI Eric Collisson · 1985 to 2026
$296.4M
Statistical MethodsP01CA087969 · NCI · BRIGHAM AND WOMEN'S HOSPITAL · PI ROSNER, BERNARD A · 2000 to 2019
$77.8M
Validity of Diet and Activity Measures in WomenP01CA055075 · NCI · HARVARD UNIVERSITY (SCH OF PUBLIC HLTH) · PI RIMM, ERIC B · 1991 to 2009
$41.8M
Tissue and Pathology ResourcesP50CA127003 · NCI · DANA-FARBER CANCER INST · PI BASS, ADAM JOEL · 2007 to 2023
$33.2M
PLCO Trial Etiologic and Early Marker StudyZIACP010152 · NCI · DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS · PI MOORE, STEVEN · 2009 to 2025
$29.9M
JH/CIDR Genotyping for Genome-Wide Association StudiesU01HG004438 · NHGRI · JOHNS HOPKINS UNIVERSITY · PI VALLE, DAVID · 2007 to 2011
$24.2M
GENETIC SUSCEPTIBILITY TO CANCER IN MULTIETHNIC COHORTSR01CA063464 · NCI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI HENDERSON, BRIAN E · 2001 to 2005
$23.2M
Multiethnic Cohort Study of Diet and CancerR37CA054281 · NCI · UNIVERSITY OF HAWAII AT MANOA · PI KOLONEL, LAURENCE N. · 2003 to 2012
$23.2M
Long Term Multidisciplinary Study of Cancer in Women: The Nurses Health StudyUM1CA186107 · NCI · BRIGHAM AND WOMEN'S HOSPITAL · PI ELIASSEN, A. HEATHER, STAMPFER, MEIR · 2014 to 2023
$22.3M
Molecular pathological epidemiology of colorectal cancerU01CA137088 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI PETERS, ULRIKE · 2009 to 2018
$21.8M
USC Consortium:Colorectal Cancer Family RegistryU01CA074799 · NCI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI HAILE, ROBERT WILLIAM · 1997 to 2008
$20.4M
VALIDATION OF A DIET HISTORY METHOD FOR EPIDEMIOLOGIC STUDIES OF CANCERP01CA033619 · NCI · UNIVERSITY OF HAWAII AT MANOA · PI KOLONEL, LAURENCE N. · 1985 to 2010
$18.5M
CCR NIH HHS HHSN261201300011CIntramural NIH HHS Z01 CP010200NCI NIH HHS HHSN261201000035CNCI NIH HHS HHSN261201000035INCI NIH HHS HHSN261201000121CNCI NIH HHS HHSN2612013000121NCI NIH HHS HHSN261201300012INCI NIH HHS HHSN261201300021CNCI NIH HHS K05 CA154337NCI NIH HHS K07 CA190673NCI NIH HHS N01 CN067009NCI NIH HHS N01-CN-67009NCI NIH HHS N01 PC035137NCI NIH HHS N01 PC035142NCI NIH HHS N01-PC-35142NCI NIH HHS P01 CA033619NCI NIH HHS P01 CA055075NCI NIH HHS P01 CA087969NCI NIH HHS P30 CA015704NCI NIH HHS P50 CA127003NCI NIH HHS R01 CA042182NCI NIH HHS R01 CA048998NCI NIH HHS R01 CA059045NCI NIH HHS R01 CA060987NCI NIH HHS R01 CA063464NCI NIH HHS R01 CA076366NCI NIH HHS R01 CA137178NCI NIH HHS R01 CA143237NCI NIH HHS R01 CA151993NCI NIH HHS R01 CA48998NCI NIH HHS R35 CA197735NCI NIH HHS R35 CA253185NCI NIH HHS R37 CA054281NCI NIH HHS U01 CA048998NCI NIH HHS U01 CA074778NCI NIH HHS U01 CA074783NCI NIH HHS U01 CA074794NCI NIH HHS U01 CA074799NCI NIH HHS U01 CA074800NCI NIH HHS U01 CA074806NCI NIH HHS U01 CA097735NCI NIH HHS U01 CA122839NCI NIH HHS U01 CA137088NCI NIH HHS U01 CA164930NCI NIH HHS U01 CA167551NCI NIH HHS U01 CA167552NCI NIH HHS U01 HG 004438NCI NIH HHS U01/U24 CA074783NCI NIH HHS U01/U24 CA074794NCI NIH HHS U01/U24 CA074799NCI NIH HHS U01/U24 CA074800NCI NIH HHS U01/U24 CA074806NCI NIH HHS U01/U24 CA097735NCI NIH HHS U19 CA148107NCI NIH HHS U24 CA074783NCI NIH HHS U24 CA074794NCI NIH HHS U24 CA074799NCI NIH HHS U24 CA074800NCI NIH HHS U24 CA074806NCI NIH HHS U24 CA097735NCI NIH HHS UM1 CA167552NCI NIH HHS UM1 CA186107NCI NIH HHS Z01 CP 010200NHGRI NIH HHS U01 HG004438NHGRI NIH HHS U01 HG004446NHLBI NIH HHS HHSN268201100001CNHLBI NIH HHS HHSN268201100001INHLBI NIH HHS HHSN268201100002CNHLBI NIH HHS HHSN268201100002INHLBI NIH HHS HHSN268201100003CNHLBI NIH HHS HHSN268201100003INHLBI NIH HHS HHSN268201100004CNHLBI NIH HHS HHSN268201100004INHLBI NIH HHS HHSN268201100046CNHLBI NIH HHS HHSN271201100004CNIA NIH HHS HHSN271201100004CNIH HHS K05 CA154337NIH HHS P01 CA033619NIH HHS P01 CA055075NIH HHS R01 CA063464NIH HHS R01 CA076366NIH HHS R01 CA143247NIH HHS R01 CA60987NIH HHS R37 CA54281NIH HHS U01 CA074783NIH HHS U01 CA122839NIH HHS U01 CA167551NIH HHS U01 CA167552NIH HHS U01 HG004446NIH HHS UM1 CA167552WHI NIH HHS HHSN268201100001CWHI NIH HHS HHSN268201100002CWHI NIH HHS HHSN268201100003CWHI NIH HHS HHSN268201100004C
6 · The paper itself

Abstract

Interindividual differences in DNA repair systems may play a role in modulating the individual risk of developing colorectal cancer. To better ascertain the role of DNA repair gene polymorphisms on colon and rectal cancer risk individually, we evaluated 15,419 single nucleotide polymorphisms (SNPs) within 185 DNA repair genes using GWAS data from the Colon Cancer Family Registry (CCFR) and the Genetics and Epidemiology of Colorectal Cancer Consortium (GECCO), which included 8,178 colon cancer, 2,936 rectum cancer cases and 14,659 controls. Rs1800734 (in MLH1 gene) was associated with colon cancer risk (p-value = 3.5 × 10

Indexed as

Genetic Predisposition to DiseaseAdultAgedBiological Variation, PopulationCarcinogenesisCase-Control StudiesColonColonic NeoplasmsDNA-Binding ProteinsDNA Modification MethylasesDNA RepairDNA Repair EnzymesFemaleHumansMaleMiddle AgedDNA-Binding ProteinsDNA Modification MethylasesDNA Repair EnzymesMGMT protein, humanMLH1 protein, humanMutL Protein Homolog 1RAD51B protein, humanTumor Suppressor Proteinscancer susceptibilitycolon cancerDNA repairgenome-wide association studiesrectal cancersingle nucleotide polymorphisms

Identifiers

PMID31209889
PMCPMC7301215
OpenAlexW2952969165

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.